Get the Stockscreener App
8.1819
11.48%
0.8427
After Hours:
14.98
6.7981
+83.09%
Metavia Inc stock is traded at $8.1819, with a volume of 159.87K.
It is up +11.48% in the last 24 hours and down -25.62% over the past month.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$7.3392
Open:
$7.7
24h Volume:
159.87K
Relative Volume:
0.67
Market Cap:
$207.82M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.39%
1M Performance:
-25.62%
6M Performance:
+7.78%
1Y Performance:
-67.66%
1-Day Range:
$7.22
$8.47
1-Week Range:
$6.05
$8.5756
52-Week Range:
$6.05
$30.25
Metavia Inc Stock (MTVA) Company Profile
Name
Metavia Inc
Sector
Industry
Phone
(857) 702-9600
Address
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
8.1819 | 16.89M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | H.C. Wainwright | Buy |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
Metavia Inc Stock (MTVA) Latest News
MetaVia Inc. (MTVA) Stock Jumps After Reverse Split: What the New Price, Trial Data and 2026 Forecast Mean for Investors - ts2.tech
Will MetaVia Inc. stock continue dividend increasesJuly 2025 Reactions & Technical Pattern Alert System - Newser
MetaVia announces 1-for-11 reverse stock split; shares slip over 15% - MSN
MetaVia Inc. (MTVA) -6.08% in After-hours: Shares Down Following Split Announcement - Stocks Telegraph
IMG, MTVA, USREF, TGL: These four stocks trade ex-reverse split on Friday - MSN
IMG, MTVA, USREF, TGL: These Four Stocks Trade Ex-Reverse Split On Friday - Stocktwits
What insider trading reveals about MetaVia Inc. stockExit Point & Risk Controlled Swing Alerts - Newser
MetaVia To Carry Out 1-for-11 Reverse Stock Split On December 5th, 2025 - 富途牛牛
MetaVia Announces Reverse Stock Split to Meet Nasdaq Rules - TipRanks
MetaVia announces 1-for-11 reverse stock split effective December 4 - Investing.com
MetaVia implements 1-for-11 reverse stock split - TipRanks
Metavia Inc. announces 1-for-11 reverse stock split - marketscreener.com
MetaVia Inc. Announces 1-for-11 Reverse Stock Split - PR Newswire
Dow Update: What margin trends mean for MetaVia Inc. stockGap Up & Long-Term Growth Plans - moha.gov.vn
Ready to Jump After Recent Trade: MetaVia Inc (MTVA) - Setenews
MetaVia Seeks Extension to Regain Nasdaq Compliance - MSN
MetaVia granted Nasdaq time to fix sub-$1.00 share price - Stock Titan
MetaVia Inc. (MTVA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will MetaVia Inc. stock maintain momentum in 2025Weekly Trade Analysis & Safe Entry Point Identification - newser.com
How MetaVia Inc. stock compares to growth peers2025 Technical Overview & Reliable Breakout Forecasts - newser.com
How MetaVia Inc. stock benefits from tech adoptionMarket Rally & Consistent Growth Equity Picks - newser.com
How MetaVia Inc. stock reacts to bond yields2025 Support & Resistance & Growth Focused Investment Plans - newser.com
How to manage a losing position in MetaVia Inc.Weekly Market Report & Daily Chart Pattern Signal Reports - newser.com
Reversal indicators forming on MetaVia Inc. stockJuly 2025 Levels & Risk Managed Investment Signals - newser.com
Real time breakdown of MetaVia Inc. stock performanceJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com
MetaVia Inc. (MTVA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Sector ETF performance correlation with MetaVia Inc.July 2025 Earnings & Weekly Top Gainers Trade List - newser.com
Metavia Inc Stock (MTVA) Financials Data
There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):